Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.

T cell factor-1 (TCF-1) and lymphoid enhancer factor-1 (LEF-1), members of the TCF/LEF family of transcription factors, play a significant role in T cell development and are expressed in thymocytes and peripheral CD3+ T cells. Previously, precursor T lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LyL) was found to express TCF-1, and we find that 9 of 10 cases of T-ALL/LyL express LEF-1 as well as TCF-1, exhibiting uniform nuclear immunostaining for both transcription factors. In addition, a significant subset of cases of peripheral T cell lymphoma (PTCL), 39 of 81 cases (48%), are immunoreactive for LEF-1 and/or TCF-1, with 36 of 38 cases immunoreactive for both, indicating that these transcription factors are coordinately expressed in PTCL. The vast majority of LEF-1+ and/or TCF-1+ PTCL (34 of 39 or 87%) exhibit a composite Th1 T-cell-like immunophenotype, based on expression of Th1 T cell-associated, but not Th2 T cell-associated, chemokine receptors and activation markers. Of the Th1-like PTCL studied, 33 of 42 (79%) were immunoreactive for LEF-1 and 32 of 42 (76%) were immunoreactive for TCF-1, including most cases of angioimmunoblastic lymphoma and all cases of lymphoepithelioid lymphoma. Surprisingly, none of the 21 cases of Th2-like PTCL studied, all cases of anaplastic large cell lymphoma, were immunoreactive for LEF-1 or TCF-1 (P < 0.0001), suggesting that LEF-1 and TCF-1 transcription factor expression may be lost in Th2 T cells or Th2-like PTCL. LEF-1 and TCF-1 immunostaining can serve to identify specific subtypes of PTCL, and lends support to a bipartite model of PTCL development, based on expression of activation markers.

[1]  K. Jones,et al.  A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. , 1991, Genes & development.

[2]  M. Karin,et al.  A novel T-cell trans-activator that recognizes a phorbol ester-inducible element of the interleukin-2 promoter. , 1990, The New biologist.

[3]  G. Pizzolo,et al.  Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. , 1995, Clinical and experimental rheumatology.

[4]  E. Serfling,et al.  One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter. , 1991, Nucleic acids research.

[5]  C. Fletcher,et al.  The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. , 1999, Blood.

[6]  M. Waterman,et al.  Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. , 1998, Nucleic acids research.

[7]  H. Kawamoto,et al.  Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus , 1996, The Journal of experimental medicine.

[8]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[9]  H Clevers,et al.  Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers , 1991, The Journal of experimental medicine.

[10]  E. Jaffe.  Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[11]  R Grosschedl,et al.  LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. , 1991, Genes & development.

[12]  L. Glimcher,et al.  Regulation of cytokine gene expression in T helper cell subsets. , 1994, Journal of immunology.

[13]  H Clevers,et al.  Two Members of the Tcf Family Implicated in Wnt/β-Catenin Signaling during Embryogenesis in the Mouse , 1998, Molecular and Cellular Biology.

[14]  Y. Miyagi,et al.  Aberrant Nuclear Localization and Gene Mutation of β-catenin in Low-Grade Adenocarcinoma of Fetal Lung Type: Up-Regulation of the Wnt Signaling Pathway May Be a Common Denominator for the Development of Tumors that Form Morules , 2002, Modern Pathology.

[15]  J. Renauld,et al.  An Animal Model for Anaplastic Large Cell Lymphoma in the Immunocompetent Syngeneic C57Bl/6 Mouse , 2000, Laboratory Investigation.

[16]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[17]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[18]  Juan F. García,et al.  Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas , 2002, Modern Pathology.

[19]  H Clevers,et al.  Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. , 1998, Immunity.

[20]  H. Clevers,et al.  Identification and cloning of TCF‐1, a T lymphocyte‐specific transcription factor containing a sequence‐specific HMG box. , 1991, The EMBO journal.

[21]  D. Dorfman,et al.  CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas. , 2002, Human pathology.

[22]  L. Cosmi,et al.  Opposite role for interleukin‐4 and interferon‐γ on CD30 and lymphocyte activation gene‐3 (LAG‐3) expression by activated naive T cells , 1997, European journal of immunology.

[23]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[24]  G. Pizzolo,et al.  In vivo CD30 expression in human diseases with predominant activation of Th2‐like T cells , 1997, Journal of leukocyte biology.

[25]  G. Lenz,et al.  Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. , 1999, Blood.

[26]  Hans Clevers,et al.  An HMG-box-containing T-cell factor required for thymocyte differentiation , 1995, Nature.

[27]  J. Delabie,et al.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. , 2001, The American journal of pathology.

[28]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[29]  F. Brombacher,et al.  IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. , 1994, International immunology.

[30]  H C Clevers,et al.  Critical involvement of Tcf-1 in expansion of thymocytes. , 1998, Journal of immunology.

[31]  V. Diehl,et al.  Characterization of a Novel Human Anaplastic Large Cell Lymphoma Cell Line Tumorigenic in SCID Mice , 2002, Leukemia & lymphoma.

[32]  H. Clevers,et al.  The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes , 1995 .

[33]  C. Fenoglio-Preiser,et al.  beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. , 2002, Cancer research.

[34]  D. Dorfman,et al.  Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. , 2000, Blood.